Charles River Laboratories International, Inc. is listed in the United States. Sector: Healthcare. Industry: Medical - Diagnostics & Research.
Charles River Laboratories International, Inc. (CRL): research close 332.16 USD on 2026-11-17. Sector: Healthcare. Historical research data, not advice.
| Fact | Figure | As of |
|---|---|---|
| Historical research close | 332.16 USD | 2026-11-17 |
| Previous research close | 335.52 USD | 2026-11-16 |
| Change between the two dated research closes | -1.00% | 2026-11-16 – 2026-11-17 |
| Market capitalisation | 16.02 billion USD | 2026-11-16 |
| 52-week range of the research close | 149.93 – 376.10 USD | 2025-11-18 – 2026-11-17 |
| One-year change in the research close | 104.10% | 2025-11-17 – 2026-11-17 |
| Average daily turnover (20 sessions) | 443.31 million USD | 2026-11-17 |
Source: us_closes_adjusted · US · research close
Historical research prices; adjustments vary by market. This is not a live quote or a forecast.
Members can compare available company evidence and explicitly save CRL to a watchlist. A company is saved only after Save is pressed for it.
Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.
Nine member offerings. Free. No card.
Join freeResearch, not advice.
Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate